Granulocyte Transfusion Therapy in Childhood.

Area of Science:

• Hematology
• Pediatric Oncology
• Infectious Diseases

Background:

• Infections remain a leading cause of death in pediatric patients with prolonged neutropenia following chemotherapy.
• Current broad-spectrum antimicrobial agents are insufficient to fully mitigate infection-related morbidity and mortality.

Purpose of the Study:

• To evaluate the efficacy and safety of granulocyte transfusions (GTs) in treating severe, life-threatening infections in pediatric patients experiencing febrile neutropenia.
• To assess the impact of GTs on neutrophil and platelet counts and clinical outcomes.

Main Methods:

• A study included 13 pediatric patients with high-risk febrile neutropenia who received a total of 24 GTs.
• Patient tolerance of GTs was monitored.
• Neutrophil and platelet counts were measured before and 24 hours after transfusion.

Main Results:

• Granulocyte transfusions were well-tolerated by all patients.
• A significant increase in neutrophil and platelet counts was observed 24 hours post-transfusion compared to baseline values.
• The study reported a 69.2% rate for both clinical response and hematologic response.

Conclusions:

• Granulocyte transfusions demonstrate safety and effectiveness in managing life-threatening infections in pediatric patients with neutropenia.
• Further randomized controlled trials with long-term follow-up are necessary to definitively establish the role of GTs in improving outcomes for neutropenic patients.